138 related articles for article (PubMed ID: 31167067)
1. Methotrexate for Prevention of Cardiovascular Events.
Huang Y; Chan AW; Shear NH
N Engl J Med; 2019 Jun; 380(23):2277. PubMed ID: 31167067
[No Abstract] [Full Text] [Related]
2. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
Landewé RB; van den Borne BE; Breedveld FC; Dijkmans BA
Lancet; 2000 May; 355(9215):1616-7. PubMed ID: 10821370
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate use in rheumatoid arthritis.
O'Dell JR
Rheum Dis Clin North Am; 1997 Nov; 23(4):779-96. PubMed ID: 9361155
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
Choi HK; Hernán MA; Seeger JD; Robins JM; Wolfe F
Lancet; 2002 Apr; 359(9313):1173-7. PubMed ID: 11955534
[TBL] [Abstract][Full Text] [Related]
6. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
7. [Methotrexate - anchor drug in the treament of rheumatoid arthritis].
Fiehn C
Dtsch Med Wochenschr; 2016 Feb; 141(3):193-5. PubMed ID: 26841182
[TBL] [Abstract][Full Text] [Related]
8. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.
Cronstein BN
Pharmacol Rev; 2005 Jun; 57(2):163-72. PubMed ID: 15914465
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Kremer JM; Weinblatt ME
Ann Rheum Dis; 2018 Jan; 77(1):e4. PubMed ID: 28596184
[No Abstract] [Full Text] [Related]
10. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
[TBL] [Abstract][Full Text] [Related]
11. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.
Rau R; Wassenberg S
J Rheumatol; 1999 Oct; 26(10):2280-1. PubMed ID: 10529157
[No Abstract] [Full Text] [Related]
12. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate treatment and mortality in rheumatoid arthritis.
Slot O
Lancet; 2002 Oct; 360(9339):1095; author reply 1097-8. PubMed ID: 12384008
[No Abstract] [Full Text] [Related]
14. Tuberculous arthritis in a patient with rheumatoid arthritis treated with methotrexate alone.
Yamato S; Mori H
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31924709
[No Abstract] [Full Text] [Related]
15. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
Rau R; Herborn G
Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
D'Andrea E; Desai RJ; He M; Glynn RJ; Lee H; Weinblatt ME; Kim SC
J Am Coll Cardiol; 2022 Jul; 80(1):36-46. PubMed ID: 35772915
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate treatment and mortality in rheumatoid arthritis.
Sibilia J; Mariette X
Lancet; 2002 Oct; 360(9339):1096-7. PubMed ID: 12384011
[No Abstract] [Full Text] [Related]
18. Methotrexate treatment and mortality in rheumatoid arthritis.
Tröger U; Bode-Böger SM
Lancet; 2002 Oct; 360(9339):1096; author reply 1097-8. PubMed ID: 12384010
[No Abstract] [Full Text] [Related]
19. TwHF versus methotrexate in the treatment of rheumatoid arthritis: response to Landewe's comment on the TRIFRA study.
Lv QW; Chen T; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
Ann Rheum Dis; 2014 Oct; 73(10):e63. PubMed ID: 25063826
[No Abstract] [Full Text] [Related]
20. Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.
Aslibekyan S; Sha J; Redden DT; Moreland LW; O'Dell JR; Curtis JR; Mikuls TR; Reynolds RJ; Danila MI; Bridges SL
Ann Rheum Dis; 2014 Apr; 73(4):785-6. PubMed ID: 24291656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
